Cardiovascular Clinical Sciences

#Atrialfibrillation (AFib) is a growing health concern. Projections indicate that over 12 million people in the U.S. will be affected by 2030. Individuals aged 65 and older are at the highest risk. Early detection and management are crucial to mitigate complications such as stroke and heart failure. We commend the American Heart Association for their unwavering commitment to educating the public on this critical issue and are working closely with industry stakeholders worldwide on advancing #research for better diagnosis and treatment options.

Genetic testing is reshaping preventive healthcare! Direct-to-Consumer Genetic Tests (DTC-GTs) help individuals understand their risk for #cardiovascular disease, enabling proactive lifestyle changes and prevention. According to a recent American Heart Association publication, these tests can: ? Identify genetic risks early for better prevention. ? Personalize healthcare decisions based on DNA insights. ? Engage patients in their long-term health. More details here: https://lnkd.in/d4vDKZMJ #GeneticTesting #PersonalizedHealth #CVHealth

Exciting News! Our Chief Medical Officer, Dr. James Udelson, will be attending the American College of Cardiology conference #ACC25 in Chicago, March 29-31. As a premier gathering of #cardiovascular experts, ACC25 is a critical platform for advancing research, discussing breakthrough innovations, and shaping the future of heart health. Event characteristics closely aligned with our continued commitment to collaborate with industry and academia towards better health outcomes for Patients worldwide. If you’re attending and would like to meet please email us at [email protected]

We are thrilled to announce that our Founder and Chief Scientific Officer, Dr. Marvin Konstam, will deliver the keynote address at the Seventh Annual Houston Shock Symposium. The event will take place between April 3rd and 5th 2025, bringing together over 130 national and international experts to discuss advancements in #cardiogenicshock management. Dr. Konstam, a globally recognized authority in heart failure and ventricular remodeling will deliver the keynote address on April 4th at 11:30 am CST at the Main Arena. He will also moderate: Session 2: The Right has left (RV Failure) on April 3rd at 3:30 pm CST Session 6: Pre-Right and Post-Left (Preload, Afterload & Hemodynamics) on April 4th at 3:30 pm CST. More info here: https://lnkd.in/gKZPeKid Meeting requests at: [email protected] #HSS25

We are thrilled to announce that our Founder and Chief Scientific Officer, Dr. Marvin Konstam, will deliver the keynote address at the Seventh Annual Houston Shock Symposium. The event will take place between April 3rd and 5th 2025, bringing together over 130 national and international experts to discuss advancements in #cardiogenicshock management. Dr. Konstam, a globally recognized authority in heart failure and ventricular remodeling will deliver the keynote address on April 4th at 11:30 am CST at the Main Arena. He will also moderate: Session 2: The Right has left (RV Failure) on April 3rd at 3:30 pm CST Session 6: Pre-Right and Post-Left (Preload, Afterload & Hemodynamics) on April 4th at 3:30 pm CST. More info here: https://lnkd.in/gKZPeKid Meeting requests at: [email protected] #HSS25

Today, on International Women’s Day, we proudly recognize and celebrate our CEO, Dr, Lorraine M. Rusch, PhD, FCP and all the wonderful women on our team whose leadership, vision, and dedication inspire us every day. At Cardiovascular Clinical Sciences, we are blessed with a culture of equality, empowerment, and innovation, ensuring that every voice is heard and valued. This year’s theme from the United Nations reminds us of the critical role women play in shaping a more inclusive and equitable world. A world where rights, opportunities, and access to healthcare are not just ideals but realities. With steadfast commitment to these ideals, we remain committed to advancing #cardiovascular research while fostering a workplace that uplifts and supports women in science, medicine, and clinical research. Join us in celebrating all the incredible women driving change in healthcare and beyond. #IWD2025 #WomenInLeadership

We are proud to participate in the American Heart Association's upcoming Boston Heart & Stroke Ball event joining other recognized stakeholders across our community and the industry to drive advancements in heart health and disease prevention. ??? When: Saturday, April 5, 2025 ?? Where: Omni Boston Hotel at the Seaport Click the link to learn more and join us: https://lnkd.in/d-qCX8us #CardiovascularResearch #HeartHealth #CommunityImpact

The very first post from our "What You Need to Know Series" A recent survey shows that nearly half of U.S. adults still believe that taking daily low-dose aspirin helps prevent heart attacks or strokes. However, guidelines since 2019 advise against this for healthy individuals due to potential bleeding risks. At Cardiovascular Clinical Sciences, we are committed to educating, increasing awareness, and sharing the latest scientific insights to support informed decision-making in cardiovascular care. If you or a loved one are taking aspirin for prevention, consult your healthcare provider to ensure it’s the right approach for you. ?? Read more here: https://lnkd.in/d9sMCkVB #HeartHealth #CardiovascularResearch #Aspirin

?? Congratulations, Sean! ?? We are thrilled to congratulate Sean Mahoney, CCRP on his well-earned promotion to Vice President of Clinical Operations! ?? Sean’s dedication over the last 14 years, expertise, and leadership have been instrumental in driving success within our team and we are excited to see him take on this new role. His passion for clinical research and commitment to excellence continue to make a significant impact across our organization and Clients. Please join us in celebrating Sean’s achievement!??

#valvedisease awareness day on February 22nd is a powerful reminder of the importance of prevention, early detection, and groundbreaking research. Affecting millions worldwide, this condition often goes undiagnosed, yet when identified early, treatment options are very effective. At Cardiovascular Clinical Sciences, we are committed to advancing research and innovation in diagnostics, therapies, and interventional treatments. ?? Know the symptoms: Fatigue, shortness of breath, chest discomfort, and dizziness. ?? Regular check-ups: Early detection is key to effective treatment. ?? Participate in research: promising clinical trials are available greatly improving disease management. https://lnkd.in/d9fQ6jwF American Heart Association